CDKN3 Antikörper (AA 1-172)
Kurzübersicht für CDKN3 Antikörper (AA 1-172) (ABIN3022822)
Target
Alle CDKN3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-172
-
Sequenz
- MKPPSSIQTS CKFKDVRRNV QKDTEELKSC GIQDIFVFCT RGELSKYRVP NLLDLYQQCG IITHHHPIAD GGTPDIASCC EIMEELTTCL KNYRKTLIHC YGGLGRSCLV AACLLLYLSD TISPEQAIDS LRDLRGSGAI QTIKQYNYLH EFRDKLAAHL SSRDSQSRSV SR
-
Kreuzreaktivität
- Human, Maus
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-172 of human CDKN3 (NP_001124323.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid freeze / thaw cycles
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
-
Andere Bezeichnung
- CDKN3
-
Hintergrund
- The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.,CDKN3,CDI1,CIP2,KAP,KAP1,Cancer,Signal Transduction,Kinase,Cell Biology & Developmental Biology,Cell Cycle,Endocrine & Metabolism,Insulin Receptor Signaling Pathway,Immunology & Inflammation,CD markers,CDKN3
-
Molekulargewicht
- 19 kDa/23 kDa
-
Gen-ID
- 1033
-
UniProt
- Q16667
Target
-